Harrison Kordestani
Algemeen Directeur bij RICH PHARMACEUTICALS, INC.
Profiel
Harrison Kordestani is currently the Chief Executive Officer & Director at Rich Pharmaceuticals, Inc. and also holds a position as Manager-Finance, Acquisitions & Production at Arclight Films Pty Ltd.
Previously, he worked as a Compliance Officer at Geopulse Exploration, Inc.
Actieve functies van Harrison Kordestani
| Bedrijven | Functie | Begin |
|---|---|---|
| RICH PHARMACEUTICALS, INC. | Algemeen Directeur | 29-06-2021 |
Arclight Films Pty Ltd.
 Arclight Films Pty Ltd. Movies/EntertainmentConsumer Services Arclight Films produces and distributes motion pictures. It focuses on international film sales and distribution services. The company has offices in Los Angeles, New York, London, Sydney, Melbourne, Toronto, and Hong Kong. The firm was founded by Victor Syrmis and Gary Hamilton in 2002 and is located in North Sydney, Australia. | Financieel Directeur/CFO | - |
Eerdere bekende functies van Harrison Kordestani
| Bedrijven | Functie | Einde |
|---|---|---|
| GEOPULSE EXPLORATION, INC. | Compliance Officer | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GEOPULSE EXPLORATION, INC. | Commercial Services |
| Bedrijven in privébezit | 2 |
|---|---|
Arclight Films Pty Ltd.
Arclight Films Pty Ltd. Movies/EntertainmentConsumer Services Arclight Films produces and distributes motion pictures. It focuses on international film sales and distribution services. The company has offices in Los Angeles, New York, London, Sydney, Melbourne, Toronto, and Hong Kong. The firm was founded by Victor Syrmis and Gary Hamilton in 2002 and is located in North Sydney, Australia. | Consumer Services |
Rich Pharmaceuticals, Inc.
 Rich Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA. | Health Technology |
